Abstract:γ-aminobutyric acid type A receptors (GABAARs) are the major mediators of synaptic inhibition in the brain. Aberrant GABAAR activity or regulation is observed in various neurodevelopmental disorders, neurodegenerative diseases and mental illnesses, including epilepsy, Alzheimer's and schizophrenia. Benzodiazepines, anesthetics and other pharmaceutics targeting these receptors find broad clinical use, but their inherent lack of receptor subtype specificity causes unavoidable side effects, raising a need for new or adjuvant medications. In this review article, we introduce a new strategy to modulate GABAeric signaling: targeting the intracellular protein interactors of GABAARs. Of special interest are scaffolding, anchoring and supporting proteins that display high GABAAR subtype specificity. Recent efforts to target gephyrin, the major intracellular integrator of GABAergic signaling, confirm that GABAAR-associated proteins can be successfully targeted through diverse molecules, including recombinant proteins, intrabodies, peptide-based probes and small molecules. Small-molecule artemisinins and peptides derived from endogenous interactors, that specifically target the universal receptor binding site of gephyrin, acutely affect synaptic GABAAR numbers and clustering, modifying neuronal transmission. Interference with GABAAR trafficking provides another way to modulate inhibitory signaling. Peptides blocking the binding site of GABAAR to AP2 increase the surface concentration of GABAAR clusters and enhance GABAergic signaling. Engineering of gephyrin binding peptides delivered superior means to interrogate neuronal structure and function. Fluorescent peptides, designed from gephyrin binders, enable live neuronal staining and visualization of gephyrin in the post synaptic sites with submicron resolution. We anticipate that in the future, novel fluorescent probes, with improved size and binding efficiency, may find wide application in super resolution microscopy studies, enlightening the nanoscale architecture of the inhibitory synapse. Broader studies on GABAAR accessory proteins and the identification of the exact molecular binding interfaces and affinities will advance the development of novel GABAAR modulators and following in vivo studies will reveal their clinical potential as adjuvant or stand-alone drugs.

Antibodies against gamma-aminobutyric acid: specificity studies and immunocytochemical results.

Antisera to gamma-aminobutyric acid. I. Production and characterization using a new model system.

Antisera to gamma-aminobutyric acid. II. Immunocytochemical application to the central nervous system.

Antibodies to Dopamine: Radioimmunological Study of Specificity in Relation to Immunocytochemistry

Gamma-Aminobutyric Acid Binding to Receptor Sites in the Rat Central Nervous System

Monoclonal antibodies specific for glial fibrillary acidic (GFA) protein and for each of the neurofilament triplet polypeptides

Monoclonal antibodies specific to the glutamic acid decarboxylase 65 kDa isoform derived from a non-obese diabetic (NOD) mouse

The Channel-Lining 6′ Amino Acid in the Second Membrane-Spanning Region of Ionotropic GABA Receptors Has More Profound Effects on 4′-Ethynyl-4- N -Propylbicycloorthobenzoate Binding Than the 2′ Amino Acid

Selective uptake of (3H)beta-alanine by glia: association with glial uptake system for GABA.

An Enzyme-Linked Immunosorbent Assay To Compare The Affinity Of Chemical Compounds For Beta-Amyloid Peptide As A Monomer

Simultaneous Determination of Γ‐aminobutyric Acid and Glutamate in Human Gastric Mucosa by HPLC, As Their Phenylisothiocyanate Derivatives

Allosteric Inhibition of a Vesicular Glutamate Transporter by an Isoform-Specific Antibody

Neither amino nor carboxyl termini are required for function of the sodium- and chloride-coupled gamma-aminobutyric acid transporter from rat brain.

A Study on the Glycan Specificity of Natural Antibody Repertoires in Rodents

Targeting GABAAR-Associated Proteins: New Modulators, Labels and Concepts

Comparison of the islet cell antibody pattern of monoclonal glutamic acid decarboxylase antibodies recognizing linear and conformational epitopes

Preparation of monoclonal antibodies specific for methyl esters of gibberellins A7 and A4

Physiological study of amino acid uptake and receptor desensitization: the GABA system in dorsal root ganglia

Specificity Controls for Immunocytochemistry

Synthesis of R‐GABA Derivatives via Pd(II) Catalyzed Enantioselective C(sp3)‐H Arylation and Virtual Validation with GABAB1 Receptor for Potential leads

A novel monoclonal IgG1 antibody specific for Galactose-alpha-1,3-galactose questions alpha-Gal epitope expression by bacteria